ADVFN - Advanced Financial Network.
HOME» NYSE » M » MRK Stock Price » MRK Stock News

Merck Share News

 Merck & Co., Stock Price
MRK Stock Price
 Merck & Co., Stock Chart
MRK Stock Chart
 Merck & Co., Stock News
MRK Stock News
 Merck & Co., Company Information
MRK Company Information
 Merck & Co., Stock Trades
MRK Stock Trades

Merck CEO's 2011 Compensation Up 41% At $13.3M

By Peter Loftus Of DOW JONES NEWSWIRES Merck & Co.'s (MRK) leader received compensation valued at $13.3 million for 2011, up 41% from the year before, reflecting his ascension to the drug maker's top post and Merck's ability to exceed certain internal performance targets. Kenneth Frazier, 57, became Merck's chief executive at the beginning of 2011 and chairman of the board in December. He was previously head of Merck's human health business. In a proxy statement filed Thursday with the U.S. Securities and Exchange Commission, Merck said certain elements of Frazier's compensation reflected growth in Merck's sales and adjusted earnings for 2011. In addition, Merck's board considered "his performance, leadership, planning and oversight during a time of continued economic, regulatory and political challenges for the healthcare industry." Earlier this year, Frazier acknowledged that Merck had a tough 2011. The company endured setbacks including negative clinical data for a once-promising heart drug, vorapaxar. Merck's full-year stock price performance lagged behind most of its large-pharmaceutical peers. But Merck of Whitehouse Station, N.J., continued to cut costs and was able to raise its dividend for the first time in seven years in 2011. Frazier said in January he was optimistic about 2012. Frazier's total compensation included: $1.5 million in salary, $3.1 million in stock awards, $3 million in option awards, $3.1 million in non-equity incentive plan compensation, and $2.6 million change in pension value and non-qualified deferred compensation earnings. In its proxy, Merck said the company exceeded internal targets for most elements of a company "scorecard" that is used partly to determine executive compensation. Merck exceeded targets for financial outcomes, customer outcomes and "internal business drivers." However, Merck didn't earn any scorecard points for "people and culture." This element of the scorecard reflects Merck's ability to create "a high-performance, sustainable culture as measured by the results of our annual employee culture survey," the proxy said. Based on results of the employee survey, "the Company failed to score any points in this category," the company said. "To earn points, some improvement over 2010 scores was required. In a year of significant transformation, restructuring and change for our employees, scores decreased slightly on the areas of focus." -By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

Stock News for Merck (MRK)
DateTimeHeadline
04/10/201409:43:48Merck: Hepatitis C Drug Shows 98% Cure Rate in Mid-Stage Trial...
04/10/201409:30:24Merck: Hepatitis C Drug Shows 98% Cure Rate in Trial
04/10/201409:09:09Merck: Hepatitis C Drug Shows 98% Cure Rate in Mid-Stage Trial
03/30/201408:46:34MARKET SNAPSHOT: Play-it-safe Stock Investors May Take Some Risk...
03/30/201408:44:49New Drugs to Lower Cholesterol Show Promise: Studies
03/28/201418:57:23Merck CEO Frazier: Consumer Unit Draws 'Substantial' Interest...
03/27/201409:44:41U.S. Hot Stocks: Hot Stocks to Watch
03/26/201416:30:44Merck, Glaxo Hold Off on Help With Affordable Care Act Copays
03/12/201415:50:24Glaxo Reports Positive Results from Asthma Drug Studies
03/12/201415:36:51GlaxoSmithKline Reports Positive Results from Asthma Drug Studies...
03/05/201414:00:05Merck, Bristol-Myers Report Positive Data
03/05/201413:50:39Merck, Bristol-Myers Report Positive Data on Investigational...
02/12/201418:27:22Merck's Sale of Consumer Business Could Fetch $10 Billion...
02/07/201417:50:50Merck to Settle Contraceptive Product Lawsuits
02/07/201417:30:19Merck to Settle Contraceptive Product-Liability Lawsuits
02/07/201411:50:13Merck to Pay $100 Million in Legal Settlement on Contraceptive...
02/05/201416:47:03MARKET SNAPSHOT: U.S. Stocks Fall; Data Stoke Fears Of Slowdown
02/05/201414:11:17MARKET SNAPSHOT: U.S. Stocks Eye Rebound; Dow Reverses Losses
02/05/201411:42:07MARKET SNAPSHOT: U.S. Stocks Fall To Session Lows After ISM...
02/05/201410:13:00MARKET SNAPSHOT: U.S. Stocks Open Lower On Weak ADP Report

Merck and other New York Stock Exchange stock quotes are delayed by at least 20 minutes.
All other stock price data is delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad